According to The Star's report on September 25, the Malaysian Ministry of Health announced that the Public Health (Control of Tobacco Products) (Amendment) Regulations 2024 (Act 852) will come into effect on October 1.
The Ministry of Health stated that the bill includes provisions on registration, sales, packaging, labeling, and banning smoking in public places. The department also emphasized in a Facebook post on Tuesday evening that the rules and regulations of the bill will also cover e-cigarettes.
In May of this year, Health Minister Datuk Seri Dr Dzulkefly Ahmad announced that the enforcement of the law will be fully implemented in June.
Previously, the Ministry of Health came under criticism for its failure to implement Act 852 due to the removal of e-cigarettes and nicotine from the list of regulated substances in the Dangerous Drugs Act by the former Health Minister Zaliha Mustafa. This resulted in the inability to enforce the provision banning the sale of e-cigarettes to minors.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
